CapsoVision (CV) vs Hyperfine (HYPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
CapsoVision (CV) has outperformed Hyperfine (HYPR) over the past year, gaining 38.9% versus a loss of 50.6%. CapsoVision is the larger company by market cap ($348.0 million vs $90.0 million), about 3.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | HYPR |
|---|---|---|
| Share price | $6.54 | $0.849 |
| Market cap | $348.00M | $90.04M |
| 1-day change | +0.62% | -2.41% |
| YTD return | -38.82% | -13.28% |
| 1-year return | +38.85% | -50.64% |
| 5-year return | — | -91.46% |
| EPS (TTM) | $-0.45 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $2.22 |
| 52-week low | $4.38 | $0.754 |
| Distance from 52-week high | -57.45% | -61.76% |
| Average volume | 158.95K | 642.03K |
| Shares outstanding | 53.21M | 90.99M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CapsoVision is about 3.9 times larger than Hyperfine by market value ($348.00M vs $90.04M).
- CV has outperformed HYPR by 89.5 percentage points over the past year.
CV vs HYPR FAQ
Which is bigger, CapsoVision or Hyperfine?
CapsoVision (CV) is larger, with a market capitalization of $348.00M compared with $90.04M for Hyperfine (HYPR).
Which stock has performed better over the past year, CV or HYPR?
CV returned +38.85% over the past 12 months, compared with -50.64% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Hyperfine in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.